News | October 19, 2023
Evonik launches Eudracap preclinic functional oral capsule for preclinical trials
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK
The company will develop and produce premixes for human nutrition applications
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Subscribe To Our Newsletter & Stay Updated
